Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.

Safeguard Scientifics

MentorTech Ventures

Merck Global Health Innovation Fund

Cigna

Guardian Life

Hermed Capital

Hikma Ventures

Maywic Select Investments

Red & Blue Ventures

Hunt Holdings

LabCorp

Marshall Wace

Merck

Prognos Health

Prognos Health is excited to announce the launch of Prognos Oncology, giving life sciences and pharmaceutical customers unprecedented access to cancer diagnostics data. This powerful platform empowers pharmaceutical companies to achieve excellence in commercial launch planning and activation, ultimately expediting access to life-saving therapies for patients in need. Learn more here: https://bit.ly/496TuPd

To hear the details about this unique and exclusive offering, join Prog Mark Reis in partnership with the Genomic Testing Cooperative tomorrow, February 8, 2024 at 11:00am Eastern Time / 8:00am Pacific Time for a webinar. Register here to attend and receive event recording: https://bit.ly/3usLAkj 

This launch furthers our mission to unlock the power of data to improve health across complex clinical populations facing challenging and life-altering conditions.

#healthcareinnovation #rwd #healthoutcomes #realworlddata 

This Thursday! Don't miss out... 

Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today.

Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/3HMnDr8

Unable to attend? Use the form above and indicate "send me the recording" and we'll send the webinar your way in 48 hours. 

Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today.

Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/48N0Xms

Mark Reis Jeffrey Owen Ahmad Charifa

GI Monitor

OnTrack Diabetes

Colonoscopy Prep Assistant

CML Monitor

HAE Monitor

Euro

DNSSEC

Google Maps

Person Schema

Accelerated Mobile Pages

VP, Life Science Solutions

Brandon Canter

Vice President of Business Development

Jim Steinberg

Vice President, Product Marketing

Lenora Harris-Field

VP, Clinical Solutions

Niyati Parikh

Sanjiv Lall

Head of Department

Bethany Slifko

Healthcare

Carole Williams

Director of Data Management & Implementations

Frank Rivera

Sales and Support

Meghan Mahoney

Business Management

Simon Lucas

David W Bryant

David Stack

Esther Dyson

Vita Cassese

Clarence So

Alan Sokolow

Joe Volpe

Swati Abbott

Sundeep Bhan

Chief Executive Officer

Jason Bhan

Chief Medical Information Officer

Steve Chase

Adam Petranovich

Chief Data Scientist

Ken Congdon

Director of Content Marketing

Cathy Wong

VP, Corporate Strategy

Matt Apprendi

VP, Marketing & Media Solutions

Daniel Berlinger

Software Development Consultant

East Coast Companies With More Than 50 Employees (Top 10K)

Private New York Companies (Top 10K)

East Coast Companies With Less Than $500M in Revenue (Top 10K)

New York Companies With Less Than $500M in Revenue (Top 10K)

Prognos Health is a health tech company that is pushing the boundaries of healthcare analytics. The company’s platform, prognosFACTOR, has the power to query billions of lab and health records on more than 325 million de-identified patients to answer clinically-focused healthcare questions in minutes, not months. The platform enables the querying and purchasing of patient-centric, HIPAA-Compliant healthcare data from the Prognos Marketplace to address diverse applications, including cohort design, patient journey studies, health outcomes, and more. Customers include 25 of the top 30 pharmaceutical manufacturers and three of the top five payers.

Venture Round - Prognos Health

Series C - Prognos Health

Series B - Prognos Health

Series A - Prognos Health

Convertible Note - Prognos Health

Computer and Software Services and Scientific Services

New York

United States

North America

Prognos Health Launches Pinpoint HCP, Revolutionizing HCP Targeting with Lab Data; Audiences First through Doceree

Derek Tancredi, MBA, CSM on LinkedIn: #healthcare #datalogistics

Livongo Partners With Prognos Health

Mark Reis on LinkedIn: Great webinar next week with our partners from Genedx and Pharming…

Unprecedented Access to Cancer Diagnostics Data with the Launch of Prognos Oncology

Prognos Health Raises $23 Million to Accelerate the Transformation of Healthcare Through Real-World Data Marketplace

Gradient AI acquires Prognos Healthcare

Gradient AI Buys Healthcare Analytics Business Unit from Prognos Health

Prognos Health Named to NYC Digital Health 100 by NYCHBL

A platform for identifying and purchasing patient-centric data, supporting clinical and commercialization efforts.

Empowers decision making across the brand lifecycle and member enrollment continuum with data-driven insights.

Analyzes de-identified patient data to optimize commercial brand strategy.

Utilizes real-world data to execute online and offline outreach to healthcare professionals.

India

Asia

Pakistan

HTML5

Google Tag Manager

Disqus

Google Fonts

F5 NGINX

Wistia

Google Analytics

HubSpot Marketing Hub

Prognos Health owns Prognos Health’s - analytics business

mPulse is a competitor of Prognos Health in the health data analytics sector, offering solutions for patient engagement and healthcare marketing.

mPulse

Health Catalyst competes with Prognos Health in the health data analytics industry, providing data and analytics solutions for healthcare organizations.

Health Catalyst

Enlitic is a competitor of Prognos Health in the health data analytics sector, specializing in medical imaging and diagnostic solutions.

Enlitic

Plenful is a competitor of Prognos Health, offering a no-code automation platform for healthcare's manual workflows.

Plenful

HealthVerity competes with Prognos Health, providing a data management platform for the healthcare industry.

HealthVerity

Phreesia is a competitor of Prognos Health, offering patient intake and engagement solutions for healthcare organizations.

Phreesia

Prognos Health leverages clinical and analytical expertise to transform diagnostic and transactional data into insight-ready information, with a focus on unlocking the power of data to improve health.

Prognos provides independent and scientifically validated analyses for companies, associations, foundations, and public clients. The company was founded in 1959 and specializes in economic, societal, and environmental studies.

news impact assignment basic	general	Mar 4, 2024 6:06 AM	aa13b776
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 6:06 AM	687d5b96
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	3811ea53
crunchbase profile	general	Nov 25, 2024 9:46 AM	0a61c384
li profile	general	Mar 4, 2024 6:06 AM	84848f8f
translate crunchbase fundingrounds	general	Nov 25, 2024 1:53 PM	47a15059
peers	general
news basic	general	Mar 4, 2024 6:06 AM	b9f842d9
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PROGNOSHEALTH

Prognos